Clinical Trial Update: Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Healthy HIV Negative Adolescents [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and immunogenicity of a TB vaccine candidate in healthy HIV-negative adolescents; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• GlaxoSmithKline TB vaccine candidate

Snippet

Sponsor: GlaxoSmithKline | Conditions: Tuberculosis | Phase 2 | Status: COMPLETED | Results posted: 2017-01-09